Related Experiment Video
Updated: May 20, 2026
08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target
1Apoptosis, Cancer and Development Laboratory, Lyon Cancer Research Center, Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France. parrigo@me.com
Current Molecular Medicine
|July 19, 2012
Summary
Human heat shock protein B1 (HspB1), also known as Hsp27, plays a role in cancer. Disrupting its structure may offer new anti-cancer drug strategies by inhibiting tumor growth and metastasis.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Human heat shock protein B1 (HspB1/Hsp27) is a molecular chaperone involved in cancer progression, metastasis, and drug resistance.
- HspB1 exhibits dynamic phosphorylation and oligomerization, suggesting its structural organization acts as a cellular sensor.
- Its interactions with various protein partners are modulated by these structural changes, influencing cellular functions.
Purpose of the Study:
- To investigate the role of HspB1's structural organization in its pro-cancer activities.
- To explore strategies for inhibiting HspB1's tumorigenic and metastatic functions.
- To identify potential therapeutic targets for anti-cancer drug development.
Main Methods:
- Analysis of HspB1 phosphorylation and oligomerization in response to cellular stress.
- Investigation of HspB1's interaction partners and their modulation by structural changes.
- Evaluation of compounds like brivudine and peptide aptamers that interfere with HspB1 structure and function.
Main Results:
- HspB1's structural organization is dynamic and responsive to cellular conditions, particularly death inducers.
- Altering HspB1's structural organization, through agents like brivudine or peptide aptamers, impairs its anti-apoptotic and tumorigenic activities.
- These interventions disrupt HspB1's interaction with inappropriate pro-cancerous partners.
Conclusions:
- HspB1's structural organization is critical for its oncogenic functions.
- Targeting HspB1's structure offers a promising strategy for developing novel anti-cancer therapeutics.
- Structure-based interference with HspB1 could lead to new drug discovery for inhibiting cancer progression and metastasis.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: